<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02660229</url>
  </required_header>
  <id_info>
    <org_study_id>OXI15-KR-401</org_study_id>
    <nct_id>NCT02660229</nct_id>
  </id_info>
  <brief_title>An Interventional Study for Patients With Cancer Pain to Evaluate the Efficacy and Safety of OxyNorm® Compared to Morphine Sulfate Through IV Continuous Infusion</brief_title>
  <acronym>SWITCH</acronym>
  <official_title>A 5-day, Multicentre, Randomized, Open-label, Parallel Group, Active Control Pilot Study to Evaluate the Efficacy and Safety of OxyNorm® (Oxycodone Hydrochloride Injection) in Comparison With Morphine Sulfate Through the IV Continuous Infusion Regimen in Patients With Cancer Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mundipharma Korea Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mundipharma Korea Ltd</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare of difference in NRS scores from baseline to the
      completion of treatment (5 days) in patients taking morphine sulfate versus oxycodone
      hydrochloride.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of OxyNorm® as measured by average NRS pain score</measure>
    <time_frame>5 days</time_frame>
    <description>Difference in NRS pain scores from baseline to the completion of treatment (5 days)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of NRS pain score(highest/current/average) from baseline to 1, 2,3 and 4 days after randomization</measure>
    <time_frame>4 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total dose of IV(IV infusion+bolus injection) study drug administered during the treatment duration</measure>
    <time_frame>5 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient's overall satisfaction with each continuous infusion on Day 3 and Day 5 after randomization</measure>
    <time_frame>3, 5 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Investigator's overall satisfaction with IV infusion on Day 3 and 5 days after randomization</measure>
    <time_frame>3, 5 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">66</enrollment>
  <condition>Cancer Pain</condition>
  <arm_group>
    <arm_group_label>Oxycodone Hydrochloride</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Brand Name: OxyNorm® Generic name: Oxycodone hydrochloride</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Morphine Sulphate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Brand name: BC Morphine sulfate Generic name: Morphine sulfate</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxycodone Hydrochloride</intervention_name>
    <description>Oxycodone injection</description>
    <arm_group_label>Oxycodone Hydrochloride</arm_group_label>
    <other_name>Oxynorm</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine Sulphate</intervention_name>
    <description>Morphine sulphate injection</description>
    <arm_group_label>Morphine Sulphate</arm_group_label>
    <other_name>BC morphine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Adult men and women aged 19 years or more

          2. Patients with cancerous pain who are hospitalized or scheduled for hospitalization at
             Screening and not planned to be discharged during the study

          3. Patients with mean moderate to severe pain over the past 7 days at Screening as
             verbally confirmed (NRS 4 or higher)

          4. Subjects who voluntarily signed the Informed Consent Form for the study

          5. Subjects who are capable of understanding details of the study and verbal
             communication on pain intensity

        Exlcusion Criteria:

          1. Patients who reached the narcotic analgesic dose corresponding to the followings for
             cancerous pain treatment immediately prior to Screening (oral morphine dose 195mg/day,
             oral oxycodone dose 130mg/day, patch fentanyl dose 75μg/hour)14)

          2. Patients with a medical history of hypersensitivity to an ingredient of oxycodone
             hydrochloride or morphine sulfate or other narcotic analgesics

          3. Patients who have contraindications and cautions when study drugs administered
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jinhyong Kang, Dr. Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul St. Mary's Hospital, The Catholic University of Korea</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul St. Mary's Hospital, The Catholic University of Korea</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 18, 2016</study_first_submitted>
  <study_first_submitted_qc>January 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 21, 2016</study_first_posted>
  <last_update_submitted>January 5, 2017</last_update_submitted>
  <last_update_submitted_qc>January 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Intravenous injection in cancer pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cancer Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Oxycodone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>May 18, 2017</submitted>
    <submission_canceled>Unknown</submission_canceled>
    <submitted>August 16, 2017</submitted>
    <returned>February 16, 2018</returned>
    <submitted>April 30, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

